Opioid-Related Disorders clinical trials
The registry lists 1,474 studies for Opioid-Related Disorders across more than 10 countries. 291 are recruiting or about to start. 1,144 of them are mainly about Opioid-Related Disorders (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-17. Counting its 2 narrower conditions too, such as Heroin Dependence: 1,559 studies, 297 open.
ClinicalTrials.gov finds 1,880 studies for Opioid-Related Disorders. How that becomes 1,474 hereChecked on ClinicalTrials.gov Nov 17, 2026
This page counts the studies the registry files under Opioid-Related Disorders, and those it files under no condition that list Opioid-Related Disordersthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. Its counts are asked again about once a week. How condition pages count
- 1,880Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
- −84Filed under a narrower condition, counted on its own pageOpiate Overdose 46 · Heroin Dependence 37
- −2List Opioid-Related Disorders as a condition, but the registry did not file them under itMost often written as “Stimulant Use & Co-occuring Opioid Use Disorders” (1) and “Maternal Opioid Use Disorder” (1). The registry filed them under other conditions only, most often Substance-Related Disorders (1) and Neonatal Abstinence Syndrome (1).
- −320Match it another way24 name it in the title, 3 in a keyword, and 293 by a synonym or other text the search reads.
- 1,474The count on this page
Get an email when these change. Save the Opioid-Related Disorders studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Who runs them
Yale University (106) · National Institute on Drug Abuse (NIDA) (76) · New York State Psychiatric Institute (42) · Johns Hopkins University (41) · University of Pennsylvania (35) · Indivior Inc. (32) · University of California, Los Angeles (23) · NYU Langone Health (23)
What is being tested here
Drugs under test in Opioid-Related Disorders studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Buprenorphine | 19 | 47 | 173 |
| Psilocybin | 5 | 0 | 9 |
| Naloxone | 4 | 11 | 53 |
| Methadone | 4 | 5 | 19 |
| Cannabidiol | 4 | 2 | 16 |
| Morphine | 3 | 2 | 9 |
| Sublocade | 2 | 4 | 12 |
| Ketamine | 2 | 1 | 9 |
| Lidocaine | 2 | 1 | 5 |
| Cannabis sativa subsp. indica TOP | 2 | 0 | 2 |
Drug classes tested here Opioids 27 open · Serotonin receptor agonists 6 open · Opioid antagonists 5 open · Local anesthetics 3 open · GLP-1 receptor agonists 3 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Jan 2027Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder · Phase 3 · New York State Psychiatric Institute
- Feb 2027Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3 · Phase 3 · Emory University
- Jun 2027Smartphones for Opiate Addiction Recovery · Phase 3 · NYU Langone Health
- Jun 2027Divided or Single Exposure (DOSE) Study · Phase 3 · University of Maryland, Baltimore
- Jun 2027Treating Polysubstance Use Using a Novel Digital Technology · Phase 3 · Friends Research Institute, Inc.
- Jul 2027Adjunctive Cannabidiol for Recovery From Opioid Study · Phase 3 · Icahn School of Medicine at Mount Sinai
- Aug 2027Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of Overdose · Phase 3 · Rhode Island Hospital
- Sep 2027Standard Versus High Dose ED-Initiated Buprenorphine Induction · Phase 3 · Yale University
- Nov 2027Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control Trial · Phase 3 · M.D. Anderson Cancer Center
- Nov 2026IMPOWR-ME Project 1: Trial of Yoga and Physical Therapy Onsite at Opioid Treatment Programs · Albert Einstein College of Medicine
Who these studies take
Of the 211 Opioid-Related Disorders studies recruiting now, 122 (58%) set no upper age limit and 75 (36%) stop at 75 or younger. 14 (7%) take children under 18. 15 (7%) are for women only and 4 (2%) for men only; 53 (25%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 5 (2%) | 5 (2%) |
| 18 | 181 (86%) | 170 (81%) |
| 30 | 200 (95%) | 189 (90%) |
| 40 | 200 (95%) | 189 (90%) |
| 50 | 198 (94%) | 188 (89%) |
| 65 | 171 (81%) | 161 (76%) |
| 75 | 147 (70%) | 137 (65%) |
| 85 | 131 (62%) | 121 (57%) |
Across all 1,474 studies, recruiting or not: 44% stop at 75 or younger and 39% at 65; 8% take children; 5% are for women only and 2% for men only; 24% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Opioid-Related Disorders studies take
Of 78 phase 1 interventional studies under Opioid-Related Disorders, half reached primary completion within 19 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 19 mo9–33 · 78 studies | — | 26 mo16–47 · 54 studies |
| Phase 1/2 | 28 mo21–37 · 14 studies | — | — |
| Phase 2 | 40 mo23–55 · 68 studies | — | 41 mo23–55 · 61 studies |
| Phase 2/3 | 52 mo35–85 · 18 studies | — | — |
| Phase 3 | 42 mo18–56 · 31 studies | — | — |
| Phase 4 | 32 mo20–55 · 52 studies | — | 35 mo21–55 · 48 studies |
| Interventional, no phase | 29 mo13–46 · 496 studies | 14 mo7–24 · 31 studies | 29 mo14–47 · 465 studies |
| Observational | 27 mo13–47 · 88 studies | — | 30 mo13–51 · 74 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 19, 2026.
Started recruiting6
- Helping Kentuckians Overcome Depression and Opioid Addiction With Brain StimulationNov 17, 2026NCT07842601
- VK4-116 Phase I Study With Food-EffectNov 13, 2026NCT06808932
- Targeting Treatment-Resistant OUD With Ketamine-Assisted Mindfulness Oriented Recovery EnhancementNov 5, 2026NCT07369089
- A Study of Cebranopadol for Opioid Withdrawal Symptoms in Adults With Chronic PainOct 23, 2026NCT07874620
- MATAspire: Mental Health Awareness Tailored App for Substance Prevention and Integrated Resilience EducationOct 22, 2026NCT06553196
Show 1 moreShow fewer
Results posted5
- A Bundled InterventionOct 28, 2026NCT06593093
- MOms in REcovery (MORE) Study: Defining Optimal CareOct 23, 2026NCT04251208
- Neurofeedback During Naturalistic Stimuli to Reduce Craving in Heroin AddictionOct 21, 2026NCT07344233
- The Kentucky Viral Hepatitis Treatment StudyOct 20, 2026NCT03949764
- Examining the Role of the Orexin System in Sleep and Stress in Persons With Opioid Use DisorderOct 20, 2026NCT04287062
Stopped1
- Low-Intensity Focused Ultrasound and the Complex PatientWithdrawnNov 9, 2026NCT06297200
Newly registered6
- Addressing Violence in the Context of Opioid Use Disorder CareNov 17, 2026NCT07943455
- Peer Recovery Support in the Homeless Health Care SettingNov 12, 2026NCT07931430
- Peer-led, Mobile App Supported Linkage to Opioid Use Disorder TreatmentOct 28, 2026NCT07900828
- Pain Sensitivity, Alcohol-Induced Analgesia, and Heavy Drinking in Individuals With Opioid Use DisorderOct 26, 2026NCT07894276
- Cannabidiol in Opioid Use Disorder and Chronic Pain With BuprenorphineOct 21, 2026NCT07886606
Show 1 moreShow fewer
Studies
Recruiting first, then most recently updated. Showing 50 of 1,474. Browse all 1,474 → or search them.
- GLP-1R Agonist Treatment for Opioid Use DisorderRecruitingNCT06548490Phase 21 country
- Helping Kentuckians Overcome Depression and Opioid Addiction With Brain StimulationRecruitingNCT07842601Not applicable1 country
- Integrated Treatment for Opioid Use Disorder and PTSDRecruitingNCT06641115Not applicable1 country
- Outcome Inference in the Sensory Preconditioning Task in Opioid-Use DisorderRecruitingNCT037453391 country
- Addressing Violence in the Context of Opioid Use Disorder CareNot yet recruitingNCT07943455Early Phase 1
- Remote Intervention to Prevent OverdoseNot yet recruitingNCT07128485Not applicable1 country
- Teaching Health Resilience in a Hospital Setting: A Peer-led InterventionRecruitingNCT06843213Not applicable1 country
- Digital Treatment for Chronic Pain and Addiction in Veterans With Opioid Use Disorder Receiving BuprenorphineNot yet recruitingNCT07361432Not applicable1 country
- VK4-116 Phase I Study With Food-EffectRecruitingNCT06808932Phase 11 country
- Improving Access to Opioid Use Disorder Treatment Among Marginalized Patients With a Tailored Telehealth InterventionNot yet recruitingNCT06341608Not applicable1 country
- Peer Recovery Support in the Homeless Health Care SettingNot yet recruitingNCT07931430Not applicable
- Development of an Opioid Withdrawal Clinical Outcome AssessmentNot yet recruitingNCT070946721 country
- Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug UseRecruitingNCT06513156Not applicable1 country
- Comparing Outpatient Treatment Retention Among Individuals Using Fentanyl Randomized to Low-dose and Direct-to-inject Buprenorphine InitiationNot yet recruitingNCT07469501Phase 41 country
- Phase 1 Study of Oral MG001Not yet recruitingNCT07204171Phase 11 country
- E-Cigarettes for Harm Reduction in Smokers With Opioid Use DisorderRecruitingNCT05722561Phase 21 country
- NOTRE: Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral SettingsNot yet recruitingNCT06854029Phase 41 country
- Opioid and Pain Treatment in Indigenous Communities (OPTIC) TrialRecruitingNCT06565416Not applicable1 country
- Prescribe to Prevent HIV: A Hybrid Trial Helping Addiction Clinics Prevent HIV & Infections Through Safer Drug Use SupportNot yet recruitingNCT07073924Not applicable1 country
- Targeting Treatment-Resistant OUD With Ketamine-Assisted Mindfulness Oriented Recovery EnhancementRecruitingNCT07369089Phase 21 country
- Disease Intervention Specialist (DIS) for SUDNot yet recruitingNCT078753611 country
- A Study of Brenipatide in Participants With Opioid Use DisorderRecruitingNCT07420283Phase 24 countries
- Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid HemorrhageRecruitingNCT07294118Phase 21 country
- Using Facebook to Support Opioid Recovery Among American Indian WomenRecruitingNCT05995886Not applicable1 country
- Behavioral Optimization for Overcoming Suboptimal Treatment Retention (BUP-BOOSTeR)Not yet recruitingNCT07607743Not applicable
- Peer-led, Mobile App Supported Linkage to Opioid Use Disorder TreatmentNot yet recruitingNCT07900828Not applicable1 country
- QAIAx - SGI/SI Smart Health Cities: Microcity Enclave Program (Quantum SI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360; USPTO EO 9424 Assignment ID: 2101042 / ARN: REEL/FRAME: 76481/0026 - OUSD-R&E, Department of War)Not yet recruitingNCT07661823Not applicable1 country
- Examining Analgesic Synergy and Efficacy in Trauma CareNot yet recruitingNCT07435077Phase 41 country
- PATH to Reducing Burnout Among Peers Who Deliver Overdose Prevention Services (R33 Phase Clinical Trial)Enrolling by invitationNCT07886944Not applicable1 country
- Real World Evaluation of the Effectiveness and Implementation of a Digital Health Therapeutic for OUDNot yet recruitingNCT07348796Not applicable1 country
- Pain Sensitivity, Alcohol-Induced Analgesia, and Heavy Drinking in Individuals With Opioid Use DisorderNot yet recruitingNCT07894276Early Phase 11 country
- A Study of Cebranopadol for Opioid Withdrawal Symptoms in Adults With Chronic PainRecruitingNCT07874620Phase 21 country
- MATAspire: Mental Health Awareness Tailored App for Substance Prevention and Integrated Resilience EducationRecruitingNCT06553196Not applicable1 country
- Cannabidiol in Opioid Use Disorder and Chronic Pain With BuprenorphineRecruitingNCT07886606Early Phase 11 country
- Ketamine for Opioid Use DisorderRecruitingNCT06943859Phase 21 country
- Impact of Collaborative Care for Pregnant Women With Opioid Use Disorder in Low-Resource Obstetric SettingsEnrolling by invitationNCT069563521 country
- Improving Jail Response to the Overdose Crisis: A Hybrid Trial of Jail ECHO to Improve MOUD Implementation and Public Health OutcomesRecruitingNCT07637994Not applicable1 country
- MethaLoad Dose-Finding StudyRecruitingNCT06877858Phase 11 country
- The ENHANCE Project ToolkitRecruitingNCT07649278Not applicable1 country
- Adapting and Implementing a Chronic Disease Self-Management Program for Primary Care Patients With Opioid Use Disorder and Serious Mental IllnessNot yet recruitingNCT07865078Not applicable
- Expanding Medication-Assisted Therapies in Central AsiaRecruitingNCT05579470Not applicable4 countries
- Recovery Management Checkup Scalability and Sustainability Hybrid ExperimentNot yet recruitingNCT07873944Phase 31 country
- Cannabis Effects on Opioid Self-AdministrationNot yet recruitingNCT07668635Phase 11 country
- The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services StudyNot yet recruitingNCT07216963Not applicable1 country
- Cortical rTMS as a Treatment for DepressionRecruitingNCT05487911Not applicable1 country
- Transcranial Direct Current Stimulation (tDCS) for Treatment of Substance Use DisorderRecruitingNCT07318480Not applicable1 country
- Semaglutide for Helping Opioid RecoveryRecruitingNCT06639464Phase 21 country
- Supporting Treatment Access and Recovery in CODRecruitingNCT05138614Not applicable1 country
- Integrating MOUD in Nonmedical Community Settings (Better Together)RecruitingNCT06416020Not applicable1 country
- Medically Supervised Ibogaine With 12-Month Digital Recovery Support for Opioid Use DisorderNot yet recruitingNCT07871877Phase 1/21 country